BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33639614)

  • 21. Follistatin-like 1 expression is decreased in the alveolar epithelium of hypoplastic rat lungs with nitrofen-induced congenital diaphragmatic hernia.
    Takahashi T; Zimmer J; Friedmacher F; Puri P
    J Pediatr Surg; 2017 May; 52(5):706-709. PubMed ID: 28188034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FSTL1 suppresses tumor cell proliferation, invasion and survival in non-small cell lung cancer.
    Ni X; Cao X; Wu Y; Wu J
    Oncol Rep; 2018 Jan; 39(1):13-20. PubMed ID: 29115636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the Adipose and Luminal Mammary Gland Compartment as Orthotopic Inoculation Sites in a 4T1-Based Immunocompetent Preclinical Model for Triple-Negative Breast Cancer.
    Steenbrugge J; Breyne K; Denies S; Dekimpe M; Demeyere K; De Wever O; Vermeulen P; Van Laere S; Sanders NN; Meyer E
    J Mammary Gland Biol Neoplasia; 2016 Dec; 21(3-4):113-122. PubMed ID: 27714576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kynurenine 3-monooxygenase upregulates pluripotent genes through β-catenin and promotes triple-negative breast cancer progression.
    Huang TT; Tseng LM; Chen JL; Chu PY; Lee CH; Huang CT; Wang WL; Lau KY; Tseng MF; Chang YY; Chiang TY; Ueng YF; Lee HC; Dai MS; Liu CY
    EBioMedicine; 2020 Apr; 54():102717. PubMed ID: 32268268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
    Takai K; Le A; Weaver VM; Werb Z
    Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cripto-1 as a novel therapeutic target for triple negative breast cancer.
    Castro NP; Fedorova-Abrams ND; Merchant AS; Rangel MC; Nagaoka T; Karasawa H; Klauzinska M; Hewitt SM; Biswas K; Sharan SK; Salomon DS
    Oncotarget; 2015 May; 6(14):11910-29. PubMed ID: 26059540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Radiofrequency ablation inhibits lung metastasis ofbreast cancer in mice].
    Deng Z; Zhang W; Han Y; Zhang S
    Zhonghua Zhong Liu Za Zhi; 2015 Jul; 37(7):497-500. PubMed ID: 26463324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Follistatin-like 1 promotes cardiac fibroblast activation and protects the heart from rupture.
    Maruyama S; Nakamura K; Papanicolaou KN; Sano S; Shimizu I; Asaumi Y; van den Hoff MJ; Ouchi N; Recchia FA; Walsh K
    EMBO Mol Med; 2016 Aug; 8(8):949-66. PubMed ID: 27234440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiation-induced lung metastasis development is MT1-MMP-dependent in a triple-negative breast cancer mouse model.
    Bouchard G; Therriault H; Geha S; Bujold R; Saucier C; Paquette B
    Br J Cancer; 2017 Feb; 116(4):479-488. PubMed ID: 28103615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blocking the FSTL1-DIP2A Axis Improves Anti-tumor Immunity.
    Kudo-Saito C; Ishida A; Shouya Y; Teramoto K; Igarashi T; Kon R; Saito K; Awada C; Ogiwara Y; Toyoura M
    Cell Rep; 2018 Aug; 24(7):1790-1801. PubMed ID: 30110636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer.
    Camorani S; Passariello M; Agnello L; Esposito S; Collina F; Cantile M; Di Bonito M; Ulasov IV; Fedele M; Zannetti A; De Lorenzo C; Cerchia L
    J Exp Clin Cancer Res; 2020 Sep; 39(1):180. PubMed ID: 32892748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resveratrol attenuates TNBC lung metastasis by down-regulating PD-1 expression on pulmonary T cells and converting macrophages to M1 phenotype in a murine tumor model.
    Han X; Zhao N; Zhu W; Wang J; Liu B; Teng Y
    Cell Immunol; 2021 Oct; 368():104423. PubMed ID: 34399171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The glycoprotein follistatin-like 1 promotes brown adipose thermogenesis.
    Fang D; Shi X; Lu T; Ruan H; Gao Y
    Metabolism; 2019 Sep; 98():16-26. PubMed ID: 31132382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innate immune activation of astrocytes impairs neurodevelopment via upregulation of follistatin-like 1 and interferon-induced transmembrane protein 3.
    Yamada S; Itoh N; Nagai T; Nakai T; Ibi D; Nakajima A; Nabeshima T; Yamada K
    J Neuroinflammation; 2018 Oct; 15(1):295. PubMed ID: 30348171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The BMP antagonist follistatin-like 1 is required for skeletal and lung organogenesis.
    Sylva M; Li VS; Buffing AA; van Es JH; van den Born M; van der Velden S; Gunst Q; Koolstra JH; Moorman AF; Clevers H; van den Hoff MJ
    PLoS One; 2011; 6(8):e22616. PubMed ID: 21826198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MIND model for triple-negative breast cancer in syngeneic mice for quick and sequential progression analysis of lung metastasis.
    Ghosh A; Sarkar S; Banerjee S; Behbod F; Tawfik O; McGregor D; Graff S; Banerjee SK
    PLoS One; 2018; 13(5):e0198143. PubMed ID: 29813119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrin α5 down-regulation by miR-205 suppresses triple negative breast cancer stemness and metastasis by inhibiting the Src/Vav2/Rac1 pathway.
    Xiao Y; Li Y; Tao H; Humphries B; Li A; Jiang Y; Yang C; Luo R; Wang Z
    Cancer Lett; 2018 Oct; 433():199-209. PubMed ID: 29964204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and characterization of mammary intraductal (MIND) spontaneous metastasis models for triple-negative breast cancer in syngeneic mice.
    Luo XL; Lin L; Hu H; Hu FL; Lin Y; Luo ML; Wang L; He YQ
    Sci Rep; 2020 Mar; 10(1):4681. PubMed ID: 32170125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of interleukin-1β by mouse mammary tumor irradiation promotes triple negative breast cancer cells invasion and metastasis development.
    Bouchard G; Therriault H; Bujold R; Saucier C; Paquette B
    Int J Radiat Biol; 2017 May; 93(5):507-516. PubMed ID: 27935337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of FSTL1 on cell proliferation in breast cancer cell line MDA‑MB‑231 and its brain metastatic variant MDA‑MB‑231‑BR.
    An J; Wang L; Zhao Y; Hao Q; Zhang Y; Zhang J; Yang C; Liu L; Wang W; Fang D; Lu T; Gao Y
    Oncol Rep; 2017 Nov; 38(5):3001-3010. PubMed ID: 29048681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.